Ensysce Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Ensysce Biosciences using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-14 | $-1.29 | $-0.90 | -43.3 % |
| Q2 | 2025-08-13 | $-0.79 | $-1.17 | 32.5 % |
| Q1 | 2025-05-13 | $-1.39 | $-2.25 | 38.2 % |
| Q4 | 2025-03-10 | $-2.90 | $-1.95 | -48.7 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-14 | $493.10K | $1.40M | -64.8 % |
| Q2 | 2025-08-13 | $1.37M | $923.85K | 48.4 % |
| Q4 | 2025-03-10 | $1.30M | $245.00K | 432.2 % |
| Q3 | 2024-11-12 | $3.42M | $250.00K | 1267.6 % |
Ensysce Biosciences (ENSC) is scheduled to report earnings on March 9, 2026. The last reported earnings were for reported on November 14, 2025 for Q3.
The Actual EPS was $-1.29, which missed the estimate of $-0.90.
The Actual Revenue was $493.1K, which missed the estimate of $1.4M.
Browse earnings estimates, EPS, and revenue on all stocks.